Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2011-03-15
2011-03-15
Oh, Taylor Victor (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
C552S653000
Reexamination Certificate
active
07906495
ABSTRACT:
New vitamin D derivative compounds containing a monohalovinyl moiety at position C-20 are described.A process for obtaining the new compounds, consisting of reacting an aldehyde precursor with a haloform in the presence of Cr2+salts, is also described.
REFERENCES:
patent: 4847012 (1989-07-01), DeLuca et al.
patent: 78704 (1983-05-01), None
patent: WO 9203414 (1992-03-01), None
patent: WO 2004037781 (2004-05-01), None
Database CA in STN, AN 106:83937 & Takai et al., J. American Chemical Society, vol. 108, n° 23, pp. 7408-7410, 1986. “Simple and selective method for aldehydes, conversion by means of a haloform-cormous chloride system”. Abstract.
Soler Carlos Mola
Teruel Antonio Conchillo
Viñas Antonio Buxadé
Laboratorios Vinas S.A.
Oh Taylor Victor
Wood Phillips Katz Clark & Mortimer
LandOfFree
Monohalogenovinyl vitamin D derivative compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monohalogenovinyl vitamin D derivative compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monohalogenovinyl vitamin D derivative compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2715912